AK963 is a potent PAK1 inhibitor that suppresses proliferation of human gastric cancer cells by downregulating the PAK1–NF-κB–cyclin B1 pathway; induces G2 phase cell cycle arrest; reduces cell migration and invasion; inhibits filopodia formation and promotes cell adhesion; and suppresses the invasive potential of gastric cancer cells by negatively regulating the PAK1–LIMK1–cofilin and PAK1–ERK–FAK pathways.